These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19875507)

  • 1. In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20).
    Jenabian MA; Saïdi H; Charpentier C; Van Herrewege Y; Son JC; Schols D; Balzarini J; Vanham G; Bélec L;
    J Antimicrob Chemother; 2009 Dec; 64(6):1192-5. PubMed ID: 19875507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential in vitro inhibitory activity against HIV-1 of alpha-(1-3)- and alpha-(1-6)-D-mannose specific plant lectins: implication for microbicide development.
    Saïdi H; Nasreddine N; Jenabian MA; Lecerf M; Schols D; Krief C; Balzarini J; Bélec L
    J Transl Med; 2007 Jun; 5():28. PubMed ID: 17565674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides.
    Gantlett KE; Weber JN; Sattentau QJ
    Antiviral Res; 2007 Sep; 75(3):188-97. PubMed ID: 17408760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C.
    Férir G; Palmer KE; Schols D
    Virology; 2011 Sep; 417(2):253-8. PubMed ID: 21802104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes.
    Balzarini J; Van Herrewege Y; Vermeire K; Vanham G; Schols D
    Mol Pharmacol; 2007 Jan; 71(1):3-11. PubMed ID: 17056872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.
    Balzarini J; Van Laethem K; Hatse S; Vermeire K; De Clercq E; Peumans W; Van Damme E; Vandamme AM; Bölmstedt A; Schols D
    J Virol; 2004 Oct; 78(19):10617-27. PubMed ID: 15367629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
    Bianchi E; Finotto M; Ingallinella P; Hrin R; Carella AV; Hou XS; Schleif WA; Miller MD; Geleziunas R; Pessi A
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12903-8. PubMed ID: 16129831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.
    Balzarini J; Hatse S; Vermeire K; Princen K; Aquaro S; Perno CF; De Clercq E; Egberink H; Vanden Mooter G; Peumans W; Van Damme E; Schols D
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3858-70. PubMed ID: 15388446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.
    Heredia A; Gilliam B; DeVico A; Le N; Bamba D; Flinko R; Lewis G; Gallo RC; Redfield RR
    AIDS; 2007 Jun; 21(10):1317-22. PubMed ID: 17545708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion.
    Nagashima KA; Thompson DA; Rosenfield SI; Maddon PJ; Dragic T; Olson WC
    J Infect Dis; 2001 Apr; 183(7):1121-5. PubMed ID: 11237840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro.
    Córdoba EV; Arnáiz E; De La Mata FJ; Gómez R; Leal M; Pion M; Muñoz-Fernández MA
    AIDS; 2013 Aug; 27(13):2053-8. PubMed ID: 23612005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.
    Tong P; Lu Z; Chen X; Wang Q; Yu F; Zou P; Yu X; Li Y; Lu L; Chen YH; Jiang S
    J Antimicrob Chemother; 2013 Nov; 68(11):2533-44. PubMed ID: 23794600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation L33M in the HR1 region of HIV-1 gp41 may play a role in T20 resistance.
    Chong H; Xu S; Zhang C; Nie J; Wang Y
    J Clin Virol; 2009 Jul; 45(3):255-8. PubMed ID: 19487156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.
    Barretina J; Blanco J; Armand-Ugón M; Gutiérrez A; Clotet B; Esté JA
    Antivir Ther; 2003 Apr; 8(2):155-61. PubMed ID: 12741628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1.
    González-Ortega E; Ballana E; Badia R; Clotet B; Esté JA
    Antiviral Res; 2011 Dec; 92(3):479-83. PubMed ID: 22027647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.
    Menzo S; Castagna A; Monachetti A; Hasson H; Danise A; Carini E; Bagnarelli P; Lazzarin A; Clementi M
    New Microbiol; 2004 Apr; 27(2 Suppl 1):51-61. PubMed ID: 15646065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR5 small-molecule antagonists and monoclonal antibodies exert potent synergistic antiviral effects by cobinding to the receptor.
    Ji C; Zhang J; Dioszegi M; Chiu S; Rao E; Derosier A; Cammack N; Brandt M; Sankuratri S
    Mol Pharmacol; 2007 Jul; 72(1):18-28. PubMed ID: 17392523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants.
    Herrera C; Cranage M; McGowan I; Anton P; Shattock RJ
    AIDS; 2011 Oct; 25(16):1971-9. PubMed ID: 21811139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide.
    Harman S; Herrera C; Armanasco N; Nuttall J; Shattock RJ
    Antimicrob Agents Chemother; 2012 May; 56(5):2347-56. PubMed ID: 22330930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
    Lawless MK; Barney S; Guthrie KI; Bucy TB; Petteway SR; Merutka G
    Biochemistry; 1996 Oct; 35(42):13697-708. PubMed ID: 8885850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.